Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.45
-0.25 (-0.74%)
Mar 10, 2026, 11:25 AM CST
-34.41%
Market Cap 2.40B
Revenue (ttm) n/a
Net Income (ttm) -141.91M
Shares Out 71.32M
EPS (ttm) -1.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46,694
Average Volume 40,405
Open 33.75
Previous Close 33.70
Day's Range 33.45 - 34.50
52-Week Range 32.65 - 56.50
Beta -0.20
RSI 33.41
Earnings Date Mar 13, 2026

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 48
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.